MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication

Exclusion Criteria

• •1. Women who are pregnant, as confirmed by serum test at time of screening, or urine pregnancy test on the day of treatment
• •2. Patient who desire to become pregnant in the future.
• •3. Patients who are breast-feeding.
• •4. Patients with an active pelvic inflammatory disease (PID)
• •5. Active local or systemic infection
• •6. Metallic implants that are incompatible with MRI
• •7. Known intolerance to the MRI contrast agent (e.g. Gadolinium or Magnevist)
• •8. Severe claustrophobia that would prevent completion of procedure in the MR unit.
• •9. Extensive abdominal scarring in the beam pass or dermoid cyst of the ovary anywhere in the treatment path.
• •10. Known or suspected pelvic carcinoma or pre-malignant conditions, including sarcoma and adenomatous hyperplasia.
• •11. Pedunculated fibroids.
• •12. Intrauterine device (IUD) anywhere in the treatment path
• •13. Undiagnosed vaginal bleeding.